Translumina, India’s coronary stent manufacturer, launches operations in the UAE

Translumina Expands Global Footprint with UAE Operations Launch

Translumina was incorporated in 2011 to specialize as a sales and marketing company
Coronary interventional devices. Since its inception, the company has established its own
Developed manufacturing capabilities and in-house product lines.

“At Translumina, we have a clear ambition to put India on the global map for medicine
devices and fulfill our national vision of ‘Make in India, Make for the World’. Indian
Engineering and innovation are at the forefront of the medical device industry
Launching our direct presence in the UAE is a step in that direction,” noted Gurmeet
Singh Suk, Co-Founder and President of Translumina Therapeutics.

Echoing this sentiment, Punita Sharma Arora, Co-Founder and Vice President
Translumina added, “We have been in international markets for over five years
It has now developed a strong direct presence in Europe and South Asia. Only at the end
Year, we have directly invested in LATAM & SEA and now in addition
In the MENA region, we are fully confident that our comprehensive product portfolio will be there
Every corner of the world can be reached.”

The company’s drug-eluting stent technologies are developed through a
A technical collaboration with the prestigious German Heart Center led to this
Development of the world’s longest researched medical devices
DES, with more than 10 years of safety and efficacy data.

Translumina purchased Blue Medical, a well-known Dutch medical device business last year due to its leadership in vascular technology and experience with drug-coated balloons.
Germany’s surgical market expands the company’s product line. Arjun
Oberoi, Managing Director of Everstone Capital and Member of the Board of Directors of Translumina,
Reflected, “We partnered with the vision to make Translumina truly global
Company. The UAE launch will coincide with the acquisition of Blue Medical and Lamet
Enhance our global presence, most importantly in the fast-growing MENA region.”

“We are delighted to establish our presence in the UAE, given its strategic importance
and business innovation,” said Translumina Group CEO Indranil Mukherjee. “It
It will allow us to better serve the MENA region while strengthening our global presence
Making high-quality healthcare more accessible.”